Periprosthetic Bone Mineral Density Changes After Implantation Of A Short Hip Stem Compared To A Straight Stem

May 14, 2017 updated by: PD Dr. med Ralf Bieger, University Hospital Ulm

Periprosthetic Bone Mineral Density Changes After Implantation Of A Short Hip Stem Compared To A Straight Stem: Five-Year Results Of A Prospective, Randomized DEXA-Analysis

The aim of this study is to evaluate periprosthetic bone mineral density (BMD) changes in the proximal femur after implantation of the Fitmore compared to the CLS stem.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

After power analysis, 140 consecutive patients were prospectively included in the randomisation protocol receiving either a Fitmore short or a CLS straight stem. The short stem was assigned in 57 (37% females) cases and the straight stem in 83 (38% females) hips. Periprosthetic bone mineral density was measured before surgery, 7 days, 3, 12 and 60 months postoperatively, using dual energy x-ray absorptiometry (DEXA). The results of the first postoperative measurement served as the baseline value. Because of the different length of the two prostheses we used adapted Gruen zones to divide the periprosthetic bone in seven regions of interest (ROI) with equal length in the proximal zones 1,2,6 and 7, only the regions 3 and 5 featured different sizes. Clinical results were recorded using the WOMAC and the Harris hip score (HHS).

Study Type

Interventional

Enrollment (Anticipated)

126

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Primary or secondary osteoarthritis of the hip
  • written informed consent
  • indication for cementless total hip arthroplasty

Exclusion Criteria:

  • previous surgery in the same hip
  • femoral fracture
  • metabolic bone disease
  • drugs affecting bone quality
  • contralateral THA within the study period
  • infectious disease or bony tumor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Fitmore short stem

Intervention: Total hip arthroplasty with an uncemented femoral short stem, the Fitmore short stem (Zimmer, Warsaw, USA). Furthermore, an uncemented cup (Allofit, Zimmer, Warzaw, USA).

Device: Fitmore Short Stem

Total hip arthroplasty was randomly performed wither either a Fitmore short or a CLS straight stem.
ACTIVE_COMPARATOR: CLS straight stem

Intervention: Total hip arthroplasty with an uncemented femoral straight stem, the CLS short stem (Zimmer, Warsaw, USA).Furthermore, an uncemented cup (Allofit, Zimmer, Warzaw, USA).

Device: CLS Straight Stem

Total hip arthroplasty was randomly performed wither either a Fitmore short or a CLS straight stem.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stem specific stress shielding of a short compared to a straight hip stem
Time Frame: Five years postoperatively
Periprosthetic Bone Mineral Density changes around a total hip arthroplasty stem
Five years postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Outcome after short compared to straight stem THA
Time Frame: Five years postoperatively
Clinical outcome measured with the Harris Hip Score and the WOMAC
Five years postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ralf Bieger, PD Dr., University Hospital Ulm - Department of Orthopedic Surgery

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2010

Primary Completion (ACTUAL)

February 1, 2012

Study Completion (ANTICIPATED)

July 1, 2017

Study Registration Dates

First Submitted

December 19, 2016

First Submitted That Met QC Criteria

May 5, 2017

First Posted (ACTUAL)

May 10, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 16, 2017

Last Update Submitted That Met QC Criteria

May 14, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Hip

Clinical Trials on Total Hip Arthroplasty

3
Subscribe